Approval · Notice of Compliance 28365 · 2022
MAEVE: Notice of Compliance 28365
Issued June 9, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28365
- Date
- June 9, 2022
- Company
- Glenmark Pharmaceuticals Canada Inc.Concord, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- To update Brand Name, Product Labels and Product Monograph. Administrative: Product Name Change
- Canadian reference product
- MICRONOR (Janssen Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MAEVE | 02458683 | Marketed |
Medicinal ingredients
- NORETHINDRONE 0.35 MG per TAB